Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for ASP Isotopes Inc. (ASPI:NASDAQ), powered by AI.
ASP Isotopes Inc. is currently trading at $6.44. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for ASP Isotopes Inc. on Alpha Lenz.
ASP Isotopes Inc.'s P/E ratio is -3.1.
“ASP Isotopes Inc. trades at a P/E of -3.1 (undervalued) with modest ROE of -138.9%.”
Ask for details →ASP Isotopes Inc. is an advanced materials company specializing in the development and commercialization of isotope enrichment technologies. Its core mission is to produce and separate isotopes vital for sectors such as nuclear medicine, green energy, pharmaceuticals, and quantum computing. Leveraging proprietary processes—including the Aerodynamic Separation Process and quantum enrichment techniques—the company aims to deliver highly enriched isotopes with enhanced commercial and environmental advantages. ASP Isotopes Inc. operates research and production facilities, including a major presence in South Africa, to support the nuclear medicine market and other specialized end-users. As a development-stage company, it serves both high-volume, low-cost applications like advanced nuclear fuels as well as high-value, low-volume needs such as medical imaging, radiotherapeutics, and certain industrial isotopes. Its activities position it as a key technology provider and prospective supplier in the global isotope supply chain, supporting innovation and growth across a variety of technologically advanced industries.
“ASP Isotopes Inc. trades at a P/E of -3.1 (undervalued) with modest ROE of -138.9%.”
Ask for details →ASP Isotopes Inc. (ticker: ASPI) is a company listed on NASDAQ in the Basic Materials sector (Chemicals). It has approximately 136 employees. Market cap is $535M.
The current price is $6.44 with a P/E ratio of -3.05x and P/B of 2.62x.
ROE is -138.93% and operating margin is -239.80%. Annual revenue is $24M.